| Product Code: ETC7649512 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Daptomycin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Daptomycin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Daptomycin Market - Industry Life Cycle |
3.4 Israel Daptomycin Market - Porter's Five Forces |
3.5 Israel Daptomycin Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Israel Daptomycin Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 Israel Daptomycin Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.8 Israel Daptomycin Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Israel Daptomycin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Israel |
4.2.2 Growing adoption of daptomycin due to its effectiveness in treating infections |
4.2.3 Rising healthcare expenditure and focus on improving healthcare infrastructure in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and use of daptomycin |
4.3.2 High cost associated with daptomycin compared to other antibiotics |
4.3.3 Competition from alternative treatment options in the Israeli market |
5 Israel Daptomycin Market Trends |
6 Israel Daptomycin Market, By Types |
6.1 Israel Daptomycin Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Daptomycin Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Israel Daptomycin Market Revenues & Volume, By Complicated Skin Structure Infections, 2021- 2031F |
6.1.4 Israel Daptomycin Market Revenues & Volume, By Bacteremia, 2021- 2031F |
6.1.5 Israel Daptomycin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Daptomycin Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 Israel Daptomycin Market Revenues & Volume, By Paediatric, 2021- 2031F |
6.2.3 Israel Daptomycin Market Revenues & Volume, By Adult, 2021- 2031F |
6.3 Israel Daptomycin Market, By Strength |
6.3.1 Overview and Analysis |
6.3.2 Israel Daptomycin Market Revenues & Volume, By 350mg, 2021- 2031F |
6.3.3 Israel Daptomycin Market Revenues & Volume, By 500mg, 2021- 2031F |
6.4 Israel Daptomycin Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Israel Daptomycin Market Revenues & Volume, By Pharmaceuticals, 2021- 2031F |
6.4.3 Israel Daptomycin Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Israel Daptomycin Market Revenues & Volume, By Wellness Centers, 2021- 2031F |
7 Israel Daptomycin Market Import-Export Trade Statistics |
7.1 Israel Daptomycin Market Export to Major Countries |
7.2 Israel Daptomycin Market Imports from Major Countries |
8 Israel Daptomycin Market Key Performance Indicators |
8.1 Rate of hospital-acquired infections in Israel |
8.2 Number of healthcare facilities adopting daptomycin |
8.3 Patient satisfaction scores with daptomycin treatment |
8.4 Rate of antibiotic resistance in bacterial strains targeted by daptomycin |
8.5 Research and development investment in new formulations or applications of daptomycin |
9 Israel Daptomycin Market - Opportunity Assessment |
9.1 Israel Daptomycin Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Israel Daptomycin Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 Israel Daptomycin Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.4 Israel Daptomycin Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Israel Daptomycin Market - Competitive Landscape |
10.1 Israel Daptomycin Market Revenue Share, By Companies, 2024 |
10.2 Israel Daptomycin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here